Lonafarnib (SCH66336) is a potent, multi-targeting farnesyltransferase inhibitor. It affects insulin/mTOR/Akt signaling pathways by blocking farnesylation and binding viral proteins, effectively inhibiting tumor growth, viral replication, and promoting apoptosis.
Lonafarnib (SCH66336) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Lonafarnib (SCH66336) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Lonafarnib (SCH66336) Mechanism of Action: Farnesyltransferase Inhibition in Fibroblast Research
- Lonafarnib (SCH66336) Clinical Trials
- Lonafarnib (SCH66336): Selectivity & Specificity
- Lonafarnib (SCH66336) Working Concentration | Cell Culture | Treatment
- Lonafarnib (SCH66336) Solubility in DMSO
- Lonafarnib (SCH66336) Stock Solution
- Lonafarnib (SCH66336) Storage
- Lonafarnib (SCH66336) Stability
- Lonafarnib (SCH66336) Combination Database
- Lonafarnib (SCH66336) Molecular Weight
- Lonafarnib (SCH66336) SMILES
- Lonafarnib (SCH66336) CAS Number
- Lonafarnib (SCH66336) Chemical Structure (2D and 3D)
- Lonafarnib (SCH66336) MedChemExpress (HY-15136)? Try a better option.
- Lonafarnib (SCH66336) Sigma (SML1457)? Try a better option.
- Lonafarnib (SCH66336) APExBIO (A4379)? Try a better option.
- Lonafarnib (SCH66336) Cayman (11746)? Try a better option.
- Lonafarnib (SCH66336) SDS｜MSDS